Clinical Rheumatology

, Volume 32, Issue 7, pp 991–998 | Cite as

Functional evaluation of the joints in acromegalic patients and associated factors

  • Leandro Lemgruber KropfEmail author
  • Miguel Madeira
  • Leonardo Vieira Neto
  • Mônica Roberto Gadelha
  • Maria Lucia Fleiuss de Farias
Original Article


This study aims to evaluate the presence of arthropathy in the large peripheral joints most commonly affected in acromegaly and to classify the severity according to the functional assessment of each joint to identify any factor that could predict the development of arthropathy and its level of severity. Seventy-one acromegalic patients were interviewed and underwent a physical examination of the knees, hips, and shoulders to identify the presence of arthropathy. The disease was functionally classified as more severe or less severe, according to a specific functional scale. We studied 21 males (29.5 %) and 50 females (70.5 %) with a mean age of 49.5 ± 14.5 years. Arthropathy in the studied joints was observed in 40 patients (prevalence of 56 %), and a statistically significant association with the presence of arthropathy was observed for three of the evaluated factors: increased body mass index (BMI), older age at diagnosis of acromegaly, and female gender. There was no association with disease control or other factors related to acromegaly. We classified 19 patients as having more functionally severe arthropathy and identified two factors associated with its development: increased BMI and lower levels of insulin-like growth factor type I. The relationship of factors such as female sex and BMI, which are also related to osteoarthritis, with arthropathy in acromegalic patients suggested a high prevalence of irreversible joint disease present at diagnosis of acromegaly. We highlight the BMI, which was associated with either the presence of arthropathy or more severe arthropathy, which demonstrates the importance of body weight control in the management of acromegalic patients.


Acromegaly complications Body mass index Joint diseases Osteoarthritis 





  1. 1.
    Marie P (1886) On two cases of acromegaly: marked hypertrophy of the upper and lower limbs and head. Rev Med 6:297–333Google Scholar
  2. 2.
    Shlomo AB, Melmed S (2008) Acromegaly. Endocrinol Metabol Clin N Am 37:101–122CrossRefGoogle Scholar
  3. 3.
    Barkan AL (2001) Acromegalic arthropathy. Pituitary 4:263–264PubMedCrossRefGoogle Scholar
  4. 4.
    Detenbeck LC, Tressler HA, O’Duffy JD, Randall RV (1973) Peripheral joint manifestations of acromegaly. Clin Orthop 91:119–127PubMedCrossRefGoogle Scholar
  5. 5.
    Colao A, Pivonello R, Scarpa R, Vallone G, Ruosi C, Lombardi G (2005) The acromegalic arthropathy. J Endocrinol Invest 28(Suppl 8):24–31PubMedGoogle Scholar
  6. 6.
    Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D et al (1998) Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 83:2121–2125PubMedCrossRefGoogle Scholar
  7. 7.
    Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM (1988) Articular manifestations of acromegaly. Aust N Z J Med 18:28–35PubMedCrossRefGoogle Scholar
  8. 8.
    Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P (1988) Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol 28:515–524CrossRefGoogle Scholar
  9. 9.
    Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH (1988) Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum 31:1022–1027PubMedCrossRefGoogle Scholar
  10. 10.
    Barkan A (1997) Acromegalic arthropathy and sleep apnea. J Endocrinol 155(Suppl 9):41–44Google Scholar
  11. 11.
    Lieberman SA, Bjorkengren AG, Hoffman AR (1992) Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21:615–631PubMedGoogle Scholar
  12. 12.
    Forgacs SS (1998) Acromegaly. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, LondonGoogle Scholar
  13. 13.
    Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW et al (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRefGoogle Scholar
  14. 14.
    Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731–2739PubMedCrossRefGoogle Scholar
  15. 15.
    Chipman JJ, Attanasio AF, Birkett MA, Bates PC, Webb S, Lamberts SW (1997) The safety profile of GH replacement therapy in adults. Clin Endocrinol 46:473–481CrossRefGoogle Scholar
  16. 16.
    Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S (1997) Acromegalic arthropathy. Ann Rheum Dis 30:243–258CrossRefGoogle Scholar
  17. 17.
    Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A et al (2004) Acromegalic axial arthropathy: a clinical case–control study. J Clin Endocrinol Metab 89:598–603PubMedCrossRefGoogle Scholar
  18. 18.
    Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529PubMedCrossRefGoogle Scholar
  19. 19.
    Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148PubMedCrossRefGoogle Scholar
  20. 20.
    D’Aubigné RM, Postel M (1954) Functional results of hip arthroplasty with acrylic prosthesis. J Bone Jt Surg Am 36-A(Suppl 3):451–475Google Scholar
  21. 21.
    Charnley J (1972) The long-term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Jt Surg Am 54-B:61–76Google Scholar
  22. 22.
    Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 248:13–14PubMedGoogle Scholar
  23. 23.
    Asif S, Choon DS (2005) Midterm results of cemented press fit condylar sigma total knee arthroplasty system. J Orthop Surg (Hong Kong) 13:280–284Google Scholar
  24. 24.
    Amstutz HC, Sew Hoy AL, Clarke IC (1981) UCLA anatomic total shoulder arthroplasty. Clin Orthop Relat Res 155:7–20PubMedGoogle Scholar
  25. 25.
    Nutton RW, McBirnie JM, Phillips C (1997) Treatment of chronic rotator-cuff impingement by arthroscopic subacromial decompression. J Bone Joint Surg Br 79:73–76PubMedCrossRefGoogle Scholar
  26. 26.
    Elmlinger MW, Kühnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP3). Clin Chem Lab Med 42:654–664PubMedCrossRefGoogle Scholar
  27. 27.
    Fellet A, Fellet AJ, Fellet L (2007) [Osteoarthritis: a review]. Rev Bras Med 64:55–61, PortugueseGoogle Scholar
  28. 28.
    Biermasz NR, Wassenaar MJ, van der Klaauw AA (2009) Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease. J Clin Endocrinol Metab 94(7):2374–2379PubMedCrossRefGoogle Scholar
  29. 29.
    Giorgi RDN (2005) [Osteoarthritis in clinical practice]. Temas Reumatol Clín 6:17–30, PortugueseGoogle Scholar
  30. 30.
    Spector TD, Nandra D, Hart DJ, Doyle DV (1997) Is hormone replacement protective for hand and knee osteoarthritis in women? The Chingford study. Ann Rheum Dis 56(7):432–434PubMedCrossRefGoogle Scholar
  31. 31.
    Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A et al (2005) Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum 35(Suppl 1):17–23PubMedCrossRefGoogle Scholar
  32. 32.
    Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65(2):312–315PubMedCrossRefGoogle Scholar
  33. 33.
    Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR et al (2010) Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporos Int 21(12):2019–2025PubMedCrossRefGoogle Scholar
  34. 34.
    Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ (2007) Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89-B:672–685CrossRefGoogle Scholar
  35. 35.
    Fortier LA, Mohammed HO, Lust G, Nixon AJ (2002) Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84-B:276–288CrossRefGoogle Scholar
  36. 36.
    Miller RE, Grodzinsky AJ, Cummings K, Plaas AH, Cole AA, Lee RT et al (2010) Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. Arthritis Rheum 62(12):3686–3694PubMedCrossRefGoogle Scholar
  37. 37.
    Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K et al (2005) Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12:1171–1179PubMedCrossRefGoogle Scholar
  38. 38.
    Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW et al (2011) Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 70(2):320–325PubMedCrossRefGoogle Scholar
  39. 39.
    Rosis RG, Massabki PS, Kairalla M (2010) [Osteoarthritis: clinical and epidemiological assessment of elderly patients in long-term institution]. Rev Bras Clin Med 8(2):101–108, PortugueseGoogle Scholar
  40. 40.
    Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81(9):646–656PubMedGoogle Scholar
  41. 41.
    East HE, Subauste JS, Gandhi A, Koch CA (2012) About secondary causes of diabetes mellitus. J Miss State Med Assoc 53(11):380–383PubMedGoogle Scholar
  42. 42.
    Wiesner TD, Trantakis C, Meixensberger J, Koch CA, Zimmer C, Paschke R (2005) Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and the results for treatment of prolactin and growth hormone secreting pituitary tumors. Med Klin 100(4):173–179CrossRefGoogle Scholar
  43. 43.
    Watson JC, Stratatkis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH (2000) Neurosurgical implications of Carney complex. J Neurosurg 92(3):413–418PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2013

Authors and Affiliations

  • Leandro Lemgruber Kropf
    • 1
    • 2
    Email author
  • Miguel Madeira
    • 1
  • Leonardo Vieira Neto
    • 1
    • 3
  • Mônica Roberto Gadelha
    • 1
  • Maria Lucia Fleiuss de Farias
    • 1
  1. 1.Division of Endocrinology, Department of Internal MedicineHospital Universitário Clementino Fraga Filho/Universidade Federal do Rio de JaneiroRio de JaneiroBrazil
  2. 2.Instituto Nacional de Traumatologia e Ortopedia (INTO)Rio de JaneiroBrazil
  3. 3.Hospital Federal da LagoaRio de JaneiroBrazil

Personalised recommendations